Lorcainide

	WikiDoc Resources for Lorcainide
Articles
Most recent articles on Lorcainide Most cited articles on Lorcainide Review articles on Lorcainide Articles on Lorcainide in N Eng J Med, Lancet, BMJ
Media
Powerpoint slides on Lorcainide Images of Lorcainide Photos of Lorcainide Podcasts & MP3s on Lorcainide Videos on Lorcainide
Evidence Based Medicine
Cochrane Collaboration on Lorcainide Bandolier on Lorcainide TRIP on Lorcainide
Clinical Trials
Ongoing Trials on Lorcainide at Clinical Trials.gov Trial results on Lorcainide Clinical Trials on Lorcainide at Google
Guidelines / Policies / Govt
US National Guidelines Clearinghouse on Lorcainide NICE Guidance on Lorcainide NHS PRODIGY Guidance FDA on Lorcainide CDC on Lorcainide
Books
Books on Lorcainide
News
Lorcainide in the news Be alerted to news on Lorcainide News trends on Lorcainide
Commentary
Blogs on Lorcainide
Definitions
Definitions of Lorcainide
Patient Resources / Community
Patient resources on Lorcainide Discussion groups on Lorcainide Patient Handouts on Lorcainide Directions to Hospitals Treating Lorcainide Risk calculators and risk factors for Lorcainide
Healthcare Provider Resources
Symptoms of Lorcainide Causes & Risk Factors for Lorcainide Diagnostic studies for Lorcainide Treatment of Lorcainide
Continuing Medical Education (CME)
CME Programs on Lorcainide
International
Lorcainide en Espanol Lorcainide en Francais
Business
Lorcainide in the Marketplace Patents on Lorcainide
Experimental / Informatics
List of terms related to Lorcainide

Lorcainide
Clinical data
ATC code	C01BC07 (WHO) ;
Identifiers
	IUPAC name N-(4-chlorophenyl)-2-phenyl-N-(1-propan-2-yl-; 4-piperidyl)acetamide;
CAS Number	59729-31-6;
PubChem CID	42884;
E number	{{#property:P628}}
ECHA InfoCard	{{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value).
Chemical and physical data
Formula	C22H27ClN2O
Molar mass	370.915 g/mol

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Lorcainide is a class 1c antiarrhythmic agent. It was discovered at Janssen Pharmaceutica in 1968.

References

Kesteloot H, Stroobandt R., Clinical experience with lorcainide (R 15 889), a new anti-arrhythmic drug, Arch Int Pharmacodyn Ther. 1977 Dec;230(2):225-34.
Carmeliet E, Janssen PA, Marsboom R, Van Nueten JM, Xhonneux R., Antiarrhythmic, electrophysiologic and hemodynamic effects of lorcainide, Arch Int Pharmacodyn Ther. 1978 Jan;231(1):104-30.

Template:Antiarrhythmic agents

Template:WikiDoc Sources

v t e Electrocardiography
Overview	History of the EKG • EKG interpretation basics • Normal sinus rhythm
EKG Complexes	P wave • QRS complex • ST Segment • T wave • T wave alternans • Tombstone T wave • U wave Osborn wave • H wave • K wave • Delta wave NSSTW changes
EKG Intervals	PR Interval • QRS Interval • ST Interval • QT Interval
Conduction System & Bradycardia	Cardiac pacemaker • SA node • AV node• Bundle of His • Purkinje fibers • Sinus bradycardia • First Degree AV Block • Second Degree AV Block • Complete or Third-Degree AV Block • Concealed conduction • AV Junctional Rhythms • LBBB • LAHB • LPHB • RBBB • Trifascicular block
Atrial Arrhythmias	Sinus tachycardia • Premature Atrial Contractions (PACs) • Ectopic Atrial Rhythm • Paroxysmal Atrial Tachycardia (PAT) • Paroxysmal Atrial Tachycardia (PAT) with Block • Multifocal Atrial Tachycardia (MAT) • Atrial Flutter • Atrial Fibrillation • Wandering atrial pacemaker
Ventricular Arrhythmias	Differential Diagnosis of Tachycardia with a Wide QRS Complex • Accelerated Idioventricular Rhythm • Ventricular Parasystole • Premature Ventricular Contractions (PVCs) • Ventricular tachycardia • Ventricular Fibrillation • Sudden cardiac death
EKG Abnormalities in Disease States	Hypertrophy & Dilatation • Right atrial enlargement • Left atrial enlargement • Biatrial enlargement • Left Ventricular Hypertrophy • Right Ventricular Hypertrophy • Biventricular Hypertrophy • Acute myocardial infarction • NSTEMI • STEMI • Tombstone ST elevation • Right ventricular myocardial infarction • Atrial infarction Pre-excitation Syndromes • Wolff-Parkinson-White Syndrome • Lown Ganong Levine Syndrome • Mahaim Type Preexcitation Cardiomyopathies • Arrhythmogenic Right Ventricular Dysplasia • Dilated Cardiomyopathy • Hypertrophic Cardiomyopathy Drug Effects on the EKG • Adenosine • β-blockers • Digitalis • Quinidine • Procainamide • Disopyramide • Lidocaine • Tocainide and Mexiletine • Phenytoin • Encainide, Flecainide and Propafenone • Amiodarone • Bretylium • Ca Channel Blockers • Phenothiazines • Tricyclic Antidepressants • Lithium Congenital Heart Disease • Dextrocardia • Atrial Septal Defect • Ventricular Septal Defect • Tetralogy of Fallot • Conjoined Twins or Siamese Twins • Congenital heart block Electrolyte Disturbances • Hyperkalemia • Hypokalemia • Hypercalcemia • Hypocalcemia • Nonspecific Changes Other Heart Diseases • Pericarditis • Myocarditis • Tamponade • Heart Transplantation • Sick Sinus Syndrome • Long QT Syndrome Inherited Disease • Brugada Syndrome Systemic Diseases • CNS Disease • Cardiac Tumors Heart Transplantation • EKG Changes in patient with Heart Transplantation Exogenous Effects • Hypothermia • Chest Trauma • Insect Bites • Electric Injuries
Technical Issues and Potential Errors in Interpretation	Artifacts • Lead Placement Errors • The EKG in a Patient with a Pacemaker • EKG in athletes

Clinical data

ATC code	C01BC07 (WHO)
Identifiers
IUPAC name N-(4-chlorophenyl)-2-phenyl-N-(1-propan-2-yl- 4-piperidyl)acetamide
CAS Number	59729-31-6
PubChem CID	42884
E number	{{#property:P628}}
ECHA InfoCard	{{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value).
Chemical and physical data
Formula	C₂₂H₂₇ClN₂O
Molar mass	370.915 g/mol

Lorcainide

Overview

References

Navigation menu